维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="van Weely"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis显示文摘	Van Weely SF van Denderen JC Steultjens MP		0，，：	1
2	Ma-rked elevation of plasma chitotriosidase activity:a novel hallmark of Gaucher disease显示文摘	Hollak CE Van Weely S Van Oers MH	1994	J Clin Invest1994，93，：	1
3	Orphan drug development across Europe:bottlenecks and opportunities显示文摘	Heemstra H E de Vrueh RL van Weely S	2008	Drug Diseov Today2008，13，1516：	1
4	Translation of rare dis- ease research into orphan drug development: disease matters显示文摘	Heemstra H E van Weely S Btiller H A	2009	DrugDiscov Today2009，14，2324：	1
5	Marked elevation of plasma ehitotriosidase activity: a novel hallmark of Gaueher disease 显示文摘	Hollak C E van Weely S van Oers M H	1994	J Clin Invest1994，93，3：	1
6	Marked elevation of plasma chitotriosidase activity,a novel hallmark of Gaucher disease显示文摘	HOLLAK C E M WEELY S VAN OVES M H J	1994	J Clin Invest1994，93，：	1
7	Orphan drug development across Europe: bottlenecks and oppor- tunities显示文摘	Heemstra HE de Vrueh RL van Weely S	2008	Drug Discovery Today2008，13，1516：	1
8	Translation of rare disease research into orphan drug development:disease matters 显示文摘	Heemstra HE van Weely S Bullet HA	2009	Drug Discov Today2009，14，2324：	1
9	Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis显示文摘	van Weely SF van Denderen JC Steultjens MP	2012	Arthritis Res Ther2012，14，2：	1
10	Marked elevation of plasma chitotriosidase activity,a novel hakkmark of Gaucher disease显示文摘	HOLLAK C E VAN WEELY S VAN OERS M H	1994	J Clin Invest1994，93，：	1
11	Translation of Rare Disease Research into Orphan Drug Development:Disease Matters显示文摘	Heemstra H E van Weely S Büller H A	2009	Drug Discovery Today2009，14，23：	1
12	Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?显示文摘	Anne E M Brabers Ellen H M Moors Sonja van Weely Remco L A de Vmeh	2011	Orphanet journal of rare diseases2011，，6：	1
13	Translation of rare disease research into orphan drug development:disease matters显示文摘	Heemstra H E van Weely S Büller H A	2009	Drug Discov Today2009，14，2324：	1
14	Novel oral treatment of Gaucher’s disease with N -butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis显示文摘	Timothy Cox Robin Lachmann Carla Hollak Johannes Aerts Sonja van Weely Martin Hrebícek Frances Platt Terry Butters Raymond Dwek Chris Moyses Irene Gow Deborah Elstein Ari Zimran	2000	The Lancet2000，，9214：	1
15	Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease显示文摘	HOLLAK C E van WEELY S van OERS M H	1994	J Clin Invest1994，93，3：	1
16	The frequency of lysosomal storage diseases in The Netherlands显示文摘	B.J.H.M. Poorthuis R.A. Wevers W.J. Kleijer J.E.M. Groener J.G.N. de Jong S. van Weely K.E. Niezen-Koning O.P. van Diggelen	1999	1999 (1-2)1999，，1：	1
17	Marked elevation of plasma chitotriosidase acifivity 显示文摘	Hollak C E van Weely S van Oers M H	1994	J Clin Invest1994，93，：	1
18	Marked elevation of plasma chitotriosidase acitivity显示文摘	Hollak CE van Weely S van Oers MH		0，，03：	1
19	Translation of rare disease research into orphan drug development:disease matters显示文摘	Heemstra H E van Weely S Buller H A	2009	Drug Discov Today2009，14，2324：	1
20	Translation of rare disease research into orphan drug development:disease matters显示文摘	Heemstra H van Weely S Buller H	2009	Drug Discov Today2009，14，2324：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示